Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 10

1.

Medical Devices and Adolescents: Points to Consider.

Samuels-Reid JH, Cope JU.

JAMA Pediatr. 2016 Nov 1;170(11):1035-1036. doi: 10.1001/jamapediatrics.2016.1351. No abstract available.

2.

Fault detection and safety in closed-loop artificial pancreas systems.

Bequette BW.

J Diabetes Sci Technol. 2014 Nov;8(6):1204-14. doi: 10.1177/1932296814543661. Review.

3.

Nonmetabolic complications of continuous subcutaneous insulin infusion: a patient survey.

Pickup JC, Yemane N, Brackenridge A, Pender S.

Diabetes Technol Ther. 2014 Mar;16(3):145-9. doi: 10.1089/dia.2013.0192.

4.

Pediatric use of insulin pump technology: a retrospective study of adverse events in children ages 1-12 years.

Cope JU, Samuels-Reid JH, Morrison AE.

J Diabetes Sci Technol. 2012 Sep 1;6(5):1053-9.

5.

Novel methodology to determine the accuracy of the OmniPod insulin pump: a key component of the artificial pancreas system.

Zisser H, Breton M, Dassau E, Markova K, Bevier W, Seborg D, Kovatchev B.

J Diabetes Sci Technol. 2011 Nov 1;5(6):1509-18.

7.

Case files of the Harvard Medical Toxicology Fellowship at Children's Hospital Boston: an insulin overdose.

Skolnik AB, Ewald MB.

J Med Toxicol. 2010 Dec;6(4):413-9. doi: 10.1007/s13181-010-0110-x. No abstract available.

8.

Evolution of diabetes insulin delivery devices.

Selam JL.

J Diabetes Sci Technol. 2010 May 1;4(3):505-13. Review.

9.

Parental involvement buffers associations between pump duration and metabolic control among adolescents with type 1 diabetes.

Wiebe DJ, Croom A, Fortenberry KT, Butner J, Butler J, Swinyard MT, Lindsay R, Donaldson D, Foster C, Murray M, Berg CA.

J Pediatr Psychol. 2010 Nov;35(10):1152-60. doi: 10.1093/jpepsy/jsq012.

10.

Insulin pump safety meeting: summary report.

Klonoff DC, Reyes JS.

J Diabetes Sci Technol. 2009 Mar 1;3(2):396-402.

Supplemental Content

Support Center